|
2024
|
Invention
|
[(4-hydroxy-1-methyl-7-phenoxyisoquinoline-3- carbonyl)amino]acetic acid (roxadustat) for the tre... |
|
|
P/S
|
Pharmaceutical products for the detection of cancer;
diagnostic antibody biomarker reagents for ... |
|
|
P/S
|
Pharmaceutical products for the detection of cancer; diagnostic antibody biomarker reagents for m... |
|
|
Invention
|
[(4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carbonyl)amino]acetic acid (roxadustat) for the trea... |
|
|
Invention
|
Solid [(4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carbonyl)amino] acetic acid. The present appli... |
|
2023
|
P/S
|
Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and s... |
|
|
Invention
|
Anti-ccr8 antibodies and uses thereof. Provided herein are isolated monoclonal antibody anti-CCR8... |
|
|
Invention
|
Modified anti-galectin-9 antibody and uses thereof. Provided herein are affinity matured anti-gal... |
|
|
Invention
|
Enhanced erythropoiesis and iron metabolism.
The present invention relates to methods and compou... |
|
|
Invention
|
Treatment for congestive heart failure.
The invention relates to treatment methods for improving... |
|
|
Invention
|
Treatment for congestive heart failure. The invention relates to treatment methods for improving ... |
|
2022
|
Invention
|
Connective tissue growth factor antibodies.
The present invention relates to antibodies that bin... |
|
|
Invention
|
Compounds, compositions and methods for histone lysine demethylase inhibition. The present disclo... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of chronic fibrotic and proliferative disorders; ph... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of chronic
fibrotic and proliferative disorders; p... |
|
|
Invention
|
Methods for treatment of motor neuron diseases.
The invention relates to methods and agents usef... |
|
|
Invention
|
Methods for treating idiopathic pulmonary fibrosis.
The present invention relates to methods and... |
|
|
Invention
|
Methods of treatment of muscular dystrophies.
The invention relates to methods and agents useful... |
|
2021
|
Invention
|
Compounds, compositions and methods for histone lysine demethylase inhibition.
The present discl... |
|
|
Invention
|
Methods for treating anemia in subjects having kidney failure using inhibitors of hypoxia-inducib... |
|
|
Invention
|
Methods of treating acute respiratory distress syndrome.
The invention relates to methods and ag... |
|
|
Invention
|
Pharmaceutical formulations of a hif hydroxylase inhibitor.
The present disclosure relates to ph... |
|
2020
|
Invention
|
Enhanced erythropoiesis and iron metabolism. The present invention relates to methods and compoun... |
|
|
P/S
|
Connective Tissue Growth Factor (CTGF) and anti-connective tissue growth factor antibodies for re... |
|
|
Invention
|
Nitrogen-containing heteroaryl compounds and methods of use thereof. The present invention relate... |
|
2019
|
Invention
|
Crystalline forms of a prolyl hydroxylase inhibitor.
The present disclosure relates to crystalli... |
|
|
P/S
|
Pharmaceutical preparations and substances. |
|
|
P/S
|
Recombinant collagens for research use; synthetic gelatin for research use; anti-connective tissu... |
|
|
P/S
|
Synthetic gelatin for research use; anti-connective tissue growth factor antibodies for research ... |
|
|
P/S
|
Synthetic gelatin for research use; anti-connective tissue
growth factor antibodies for research... |
|
|
P/S
|
Recombinant collagens for research use; synthetic gelatin
for research use; anti-connective tiss... |
|
2018
|
P/S
|
Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovas... |
|
|
Invention
|
Methods of treating didiopathic pulmonary fibrosis. The present invention relates to methods and ... |
|
|
Invention
|
Methods of treating idiopathic pulmonary fibrosis.
The present invention relates to methods and ... |
|
|
P/S
|
Recombinant collagens for research use; synthetic gelatin for research use; recombinant collagen ... |
|
|
P/S
|
anti-connective tissue growth factor antibodies for research and diagnostic use; prolyl hydroxyla... |
|
|
Invention
|
Pharmaceutical formulations of a hif hydroxylase inhibitor. The present disclosure relates to pha... |
|
|
Invention
|
Methods for treating idiopathic pulmonary fibrosis. The present invention relates to methods and ... |
|
|
Invention
|
Crystalline forms of a prolyl hydroxylase inhibitor. The present disclosure relates to crystallin... |
|
2017
|
Invention
|
Methods for treating a neurological disorder in a subject using inhibitors of hypoxia-inducible f... |
|
2016
|
P/S
|
Pharmaceutical and veterinary preparations; sanitary
preparations for medical purposes; dietetic... |
|
|
P/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic ... |
|
|
Invention
|
Methods for treatment of motor neuron diseases. The invention relates to methods and agents usefu... |
|
|
P/S
|
Pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of... |
|
|
Invention
|
Process for making isoquinoline compounds. The present invention relates to methods for making is... |
|
|
Invention
|
Naphthyridine derivatives as inhibitors of hypoxia inducible factor (hif) hydroxylase. The presen... |
|
2009
|
P/S
|
Anti-connective tissue growth factor antibodies for clinical or pharmaceutical use |
|
|
P/S
|
Chemicals used in industry, science and photography, as well as in agriculture, horticulture and ... |
